QDELQUIDEL CORP /DE/

Nasdaq www.quidel.com


$ 40.81 $ 0.42 (1.04 %)    

Wednesday, 24-Apr-2024 15:59:58 EDT
QQQ $ 422.96 $ 1.44 (0.34 %)
DIA $ 384.57 $ -0.58 (-0.15 %)
SPY $ 502.89 $ -0.24 (-0.05 %)
TLT $ 88.37 $ -0.63 (-0.71 %)
GLD $ 214.61 $ -0.40 (-0.19 %)
$ 40.82
$ 39.88
$ 0.00 x 0
$ 0.00 x 0
$ 39.22 - $ 40.83
$ 37.78 - $ 95.02
944,800
na
1.73B
$ 0.27
$ 1.72
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-04-2022 03-31-2022 10-Q
2 02-18-2022 12-31-2021 10-K
3 11-04-2021 09-30-2021 10-Q
4 08-05-2021 06-30-2021 10-Q
5 05-07-2021 03-31-2021 10-Q
6 02-19-2021 12-31-2020 10-K
7 10-30-2020 09-30-2020 10-Q
8 07-31-2020 06-30-2020 10-Q
9 05-07-2020 03-31-2020 10-Q
10 02-13-2020 12-31-2019 10-K
11 10-31-2019 09-30-2019 10-Q
12 08-09-2019 06-30-2019 10-Q
13 05-09-2019 03-31-2019 10-Q
14 02-15-2019 12-31-2018 10-K
15 11-07-2018 09-30-2018 10-Q
16 08-08-2018 06-30-2018 10-Q
17 05-09-2018 03-31-2018 10-Q
18 02-27-2018 12-31-2017 10-K
19 11-02-2017 09-30-2017 10-Q
20 07-27-2017 06-30-2017 10-Q
21 04-27-2017 03-31-2017 10-Q
22 02-16-2017 12-31-2016 10-K
23 10-28-2016 09-30-2016 10-Q
24 07-28-2016 06-30-2016 10-Q
25 04-29-2016 03-31-2016 10-Q
26 02-23-2016 12-31-2015 10-K
27 10-29-2015 09-30-2015 10-Q
28 07-23-2015 06-30-2015 10-Q
29 04-24-2015 03-31-2015 10-Q
30 02-24-2015 12-31-2014 10-K
31 10-24-2014 09-30-2014 10-Q
32 07-24-2014 06-30-2014 10-Q
33 04-25-2014 03-31-2014 10-Q
34 02-27-2014 12-31-2013 10-K
35 10-25-2013 09-30-2013 10-Q
36 07-31-2013 06-30-2013 10-Q
37 04-24-2013 03-31-2013 10-Q
38 02-22-2013 12-31-2012 10-K
39 10-29-2012 09-30-2012 10-Q
40 07-27-2012 06-30-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

 whats-going-with-covid-19-test-maker-quidelortho-stock-on-tuesday

QuidelOrtho secures FDA approval for QuickVue COVID-19 test, catering to home and medical settings. Despite Savanna RVP4+ assay...

 quidelortho-receives-fda-clearance-for-quickvue-covid-19-test

Test Delivers on Company Commitment to Advance the Power of Diagnostics to Empower Patients with Rapid Results in Just 10 Minut...

 ubs-downgrades-quidelortho-to-sell-lowers-price-target-to-42

UBS analyst John Sourbeer downgrades QuidelOrtho (NASDAQ:QDEL) from Neutral to Sell and lowers the price target from $70 to ...

 quidelortho-makes-correction-to-2024-guidance-to-widen-range-for-adj-eps-to-align-with-adj-ebitda-guidance-now-sees-adj-eps-of-188-360-vs--february-13-outlook-of-240-307-est-374

On February 13, 2024, QuidelOrtho ssued a press release announcing the financial results for its fourth quarter and full year e...

 dow-edges-higher-quidelortho-shares-plummet

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. ...

 stocks-rebound-as-investor-focus-shifts-to-earnings-bitcoin-tops-1-trillion-value-whats-driving-markets-wednesday

The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation ...

 why-sony-shares-are-trading-lower-by-around-6-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financi...

 quidelortho-analysts-cut-their-forecasts-after-downbeat-results

QuidelOrtho Corp (NASDAQ: QDEL) posted weaker-than-expected results for its fourth quarter on Tuesday.

 why-is-diagnostic-maker-quidelortho-stock-crashing-wednesday

QuidelOrtho's Q4 2023 EPS at $1.17, below consensus $2.05. Sales: $742.6M, missing estimate $796.91M. Respiratory revenue d...

 craig-hallum-downgrades-quidelortho-to-hold

Craig-Hallum analyst Alexander Nowak downgrades QuidelOrtho (NASDAQ:QDEL) from Buy to Hold.

 crude-oil-moves-lower-louisiana-pacific-posts-upbeat-earnings

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday. The Dow traded d...

 rbc-capital-maintains-outperform-on-quidelortho-lowers-price-target-to-81

RBC Capital analyst Conor McNamara maintains QuidelOrtho (NASDAQ:QDEL) with a Outperform and lowers the price target from $1...

 raymond-james-downgrades-quidelortho-to-outperform-lowers-price-target-to-76

Raymond James analyst Andrew Cooper downgrades QuidelOrtho (NASDAQ:QDEL) from Strong Buy to Outperform and lowers the price ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION